TFF3 and metabolic dysfunction-associated steatotic liver disease: Conversely, intraperitoneal injection of recombinant TFF3 protein or tail-vein injection of adenovirus-mediated TFF3 overexpression ameliorated several indicators associated with NAFLD in diabetic and obese mice.